China SXT Pharmaceuticals annual gross profit
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
China SXT Pharmaceuticals Gross Profit Growth & History (SXTC)
China SXT Pharmaceuticals's gross profit was $248,702 for fiscal 2026.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $248,702 | −$118,725 | −32.31% |
| 2025 | 2025-03-31 | $367,427 | −$186,544 | −33.67% |
| 2024 | 2024-03-31 | $553,971 | $127,700 | +29.96% |
| 2023 | 2023-03-31 | $426,271 | −$825,372 | −65.94% |
| 2022 | 2022-03-31 | $1.3M | −$1.6M | −55.92% |
| 2021 | 2021-03-31 | $2.8M | $135,848 | +5.02% |
| 2020 | 2020-03-31 | $2.7M | −$1.9M | −41.37% |
| 2019 | 2019-03-31 | $4.6M | $1.2M | +35.57% |
| 2018 | 2018-03-31 | $3.4M | $1.1M | +47.12% |
| 2017 | 2017-03-31 | $2.3M | — | — |
China SXT Pharmaceuticals gross profit trends
Over the last five fiscal years, China SXT Pharmaceuticals's gross profit decreased from $2.8M to $248,702, a change of −$2.6M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China SXT Pharmaceuticals source filings ↗